%0 Journal Article
%A 
%T Pazopanib or Sunitinib as First-Line Treatment in metastatic Renal Cell Cancers: A Retrospective Comparative Analysis of Survival and Toxicity Outcomes
%D 2025
%F 
%P 97-104
%V 9
%N 2
%R doi:10.14744/ejmi.2025.81571
%U https://dx.doi.org/10.14744/ejmi.2025.81571